CCL26 and Burkitt lymphoma: Baseline cytokine levels in the BL cohort revealed statistically significant differences in terms of survival analyses for eotaxin-3, FGF-9, IP10, NT-3, IL10, MDC, and MIF independently (data not shown). Subsequently, two scores based on these cytokines were developed using IL-10, MDC, MIF, and eotaxin-3 for PFS analysis (Figure 1A) and eotaxin-3, NT-3, FGF-9, and IP-10 for OS analysis (Figure 1B).